The role of KPNA3 in multiple myeloma: implications for targeting nuclear import

Hongmei Luo1, Ziyue Mi2, Jingcao Huang2

  • 1Department of Hematology/Institute of Hematology Research, West China Hospital, Sichuan University, Chengdu, China. 957646155@qq.com.

Insights

Importin α4 (KPNA3) is highly expressed in multiple myeloma (MM) and drives tumor growth. Targeting KPNA3 with ivermectin (IVM) shows promise for MM treatment by inhibiting proliferation and promoting apoptosis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Multiple myeloma (MM) is a malignant plasma cell tumor with no current cure.
  • Importin α4 (KPNA3) is part of the importin α/β system, crucial for transporting substances into the cell nucleus.
  • The role of KPNA3 in MM pathogenesis and its therapeutic potential are largely unexplored.

Purpose of the Study:

  • To investigate the expression and function of KPNA3 in multiple myeloma.
  • To explore the therapeutic potential of targeting KPNA3 in MM.
  • To identify novel therapeutic strategies for MM.

Main Methods:

  • Quantitative analysis of KPNA3 expression in MM patient samples.
  • In vitro and in vivo studies involving KPNA3 knockdown in MM cells.
  • Investigation of KPNA3's effect on ALDH2 transcription and hedgehog pathway activity.
  • Assessment of ivermectin (IVM) binding to KPNA3 and its effects on MM cells.
  • Evaluation of synergistic effects of IVM and selinexor in MM models.

Main Results:

  • KPNA3 is highly expressed in MM, with higher levels correlating with poorer patient prognosis.
  • KPNA3 knockdown inhibited MM cell proliferation, induced apoptosis, and enhanced drug sensitivity.
  • KPNA3 knockdown suppressed ALDH2 transcription and downregulated hedgehog pathway activity.
  • Ivermectin (IVM) directly binds to KPNA3, reducing its protein levels and promoting MM cell apoptosis.
  • IVM and selinexor demonstrated synergistic anti-MM activity in vitro and in vivo.

Conclusions:

  • KPNA3 plays a significant role in the development and progression of multiple myeloma.
  • Targeting the nuclear import mediated by KPNA3 presents a promising therapeutic strategy for MM.
  • Ivermectin (IVM) emerges as a potential therapeutic agent for MM, particularly in combination therapy.

Related Concept Videos

Nuclear Localization Signals and Import01:46

Nuclear Localization Signals and Import

Proteins targeted to the nucleus carry short stretches of amino acid sequences called the nuclear localization signal or NLS. Classical nuclear localization signals are of two types: monopartite and bipartite NLS. Monopartite classical NLS (cNLS) consists of a single cluster of 4-8 amino acids. Bipartite cNLS consists of two clusters of  2-3 amino acids and a 9-12 residue long proline-rich linker bridging the two clusters. Signal clusters are rich in positively charged amino acids such as...
8.1K
Nuclear Protein Sorting01:34

Nuclear Protein Sorting

Nuclear protein sorting is the selective trafficking of histones, polymerases, gene regulatory proteins into the nucleus and exporting RNAs and ribosomes to the cytosol. It is a tightly controlled process that regulates gene expression within a cell.
Proteins targeted to the nucleus carry nuclear localization signals or NLS recognized by import receptors in the cytosol. Similarly, proteins with nuclear export signals are recognized by export receptors. Import and export receptors are...
6.6K
Nuclear Export01:42

Nuclear Export

The nucleus restricts several proteins within and allows others to pass. The restricted proteins possess a nuclear retention sequence or NRS, anchoring them to the nuclear lamins and preventing their transport to the cytosol. The non-restricted proteins, after their synthesis, are transported to their site of action, such as the cytosol or other organelles, with the help of nuclear export signals or NES.
NES are of three types- the canonical 10-residue long leucine-rich signal and other...
5.1K
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
3.4K
Directionality of Nuclear Transport01:42

Directionality of Nuclear Transport

Ras-related nuclear protein or Ran is a small G protein that cycles between its GTP and GDP bound states. Ran specific regulators, a Ran GTPase Activating Protein or RanGAP present in the cytosol and a Ran guanine nucleotide exchange factor or RanGEF present inside the nucleus regulate GTP/GDP exchange. A high concentration of GTP inside the cells, in addition to this asymmetric distribution of  Ran-specific regulators, leads to a higher RanGTP concentration inside the nucleus. This...
4.8K
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
10.6K